{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:33:33Z","timestamp":1787758413732,"version":"build-2784847793"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The causal association between IgA nephropathy (IgAN) and celiac disease (CeD) is based on their clinical coexistence. In this prospective study, we screened patients with IgAN for CeD and explored the utility of analysis of IgA anti-TG2 antibody deposits, for establishing a causal association.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Biopsy-proven patients of IgAN were screened for serum IgA anti-tissue transglutaminase antibody (IgA anti-tTG Ab) titer and thereafter were invited to undergo endoscopic duodenal biopsy. Corresponding duodenal and kidney biopsies were subjected to IgA anti-TG2 antibody colocalization study using dual-color immunohistochemistry and immunofluorescence techniques. Additionally, kidney biopsies from 105 patients with IgAN who did not give consent for serology analysis, 30 non-IgA nephropathies, and 10 normal controls were also included. Dual-color-stained slides were interpreted based on stain distribution and intensity scores, and Pearson's index &gt;0.3\u20131 on confocal imaging was considered significant.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Of a cohort of 151 patients with IgAN, 32 consented to undergo sero-screening and 5 of them had high serum anti-tTG Ab titer. Two out of the latter consented to endoscopic duodenal biopsies, in whom modified Marsh grade 3b changes were identified. Strong IgA anti-TG2 antibody deposits were noted in the kidney and duodenal biopsies of these patients. One patient out of non-consenting 105 patients with IgAN and 3 out of 30 patients with other non-IgA nephropathies also showed IgA anti-TG2 deposits. None of the healthy kidney tissues showed IgA anti-TG2 Ab deposits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Co-localized IgA anti-TG2 deposits in the kidney biopsies in patients with IgAN help to establish a pathogenic link with CeD. A small proportion of patients with IgAN have associated CeD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjg.sjg_326_22","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T05:11:42Z","timestamp":1667538702000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Identification of celiac disease associated IgA nephropathy by IgA anti-tissue transglutaminase2 antibody deposits in archived formalin-fixed tissues"],"prefix":"10.4103","volume":"29","author":[{"given":"Rimlee","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakant","family":"Rawat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasenjit","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alka","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzafer","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Agrawal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Govind K.","family":"Makharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20240829","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/nu10060755","article-title":"Extra-intestinal manifestation of celiac disease in children","volume":"10","author":"Jericho","year":"2018","journal-title":"Nutrients"},{"key":"R2-9-20240829","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1159\/000509997","article-title":"A personalized update on IgA nephropathy: A new vision and new future challenges","volume":"144","author":"Guti\u00e9rrez","year":"2020","journal-title":"Nephron"},{"key":"R3-9-20240829","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1093\/ndt\/gfp294","article-title":"Aberrant galactosylation of IgA1 is involved in the genetic susceptibility of Chinese patients with IgA nephropathy","volume":"24","author":"Lin","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R4-9-20240829","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/nu13051594","article-title":"Celiac disease-type tissue transglutaminase autoantibody deposits in kidney biopsies of patients with IgA nephropathy","volume":"13","author":"Nurmi","year":"2021","journal-title":"Nutrients"},{"key":"R5-9-20240829","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/j.1572-0241.2002.06025.x","article-title":"Celiac disease and HLA DQ in patients with IgA nephropathy","volume":"97","author":"Collin","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"R6-9-20240829","first-page":"161","article-title":"A case report: A patient with IgA nephropathy and coeliac disease. Complete clinical remission following gluten-free diet","volume":"2","author":"Koivuviita","year":"2009","journal-title":"NDT Plus"},{"key":"R7-9-20240829","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1084\/jem.20112005","article-title":"Transglutaminase is essential for IgA nephropathy development acting through IgA receptors","volume":"209","author":"Berthelot","year":"2012","journal-title":"J Exp Med"},{"key":"R8-9-20240829","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ki.2015.94","article-title":"Gluten exacerbates IgA nephropathy in humanized mice through gliadin\u2013CD89 interaction","volume":"88","author":"Papista","year":"2015","journal-title":"Kidney Int"},{"key":"R9-9-20240829","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1097\/MCG.0b013e318284792e","article-title":"Increased risk of IgA nephropathy among individuals with celiac disease","volume":"47","author":"Welander","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R10-9-20240829","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ki.2015.149","article-title":"Gluten and IgA nephropathy: You are what you eat?","volume":"88","author":"Cheung","year":"2015","journal-title":"Kidney Int"},{"key":"R11-9-20240829","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12876-018-0792-0","article-title":"Case report on pathogenetic link between gluten and IgA nephropathy","volume":"18","author":"Costa","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"R12-9-20240829","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.jceh.2018.06.499","article-title":"Analysis of histological features and co-localisation patterns of IGA and IGG anti-tissue transglutaminase antibody in liver biopsies of patients with treatment na\u00efve celiac disease, presenting with liver dysfunctions","volume":"8","author":"Dutta","year":"2018","journal-title":"J Clin Exp Hepatol"},{"key":"R13-9-20240829","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1007\/s10620-021-07246-1","article-title":"Pan-gastrointestinal tract mucosal pathologies in patients with celiac disease with the demonstration of IgA anti-transglutaminase mucosal deposits: A case\u2013control study","volume":"67","author":"Chauhan","year":"2022","journal-title":"Dig Dis Sci"},{"key":"R14-9-20240829","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/PAI.0000000000000430","article-title":"Immunohistochemical expression of antitissue transglutaminase 2 in tissue injuries: An interpretation beyond celiac disease","volume":"26","author":"Das","year":"2018","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"R15-9-20240829","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: Time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R16-9-20240829","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1681\/ASN.2006060658","article-title":"O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy","volume":"17","author":"Smith","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R17-9-20240829","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nm0797-797","article-title":"Identification of tissue transglutaminase as the autoantigen of celiac disease","volume":"3","author":"Dieterich","year":"1997","journal-title":"Nat Med"},{"key":"R18-9-20240829","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1582-4934.2008.00325.x","article-title":"Mucosal tissue transglutaminase expression in celiac disease","volume":"13","author":"Villanacci","year":"2009","journal-title":"J Cellular Mol Med"},{"key":"R19-9-20240829","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/gut.2003.024836","article-title":"in vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies","volume":"53","author":"Korponay-Szab\u00f3","year":"2004","journal-title":"Gut"},{"key":"R20-9-20240829","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/MPG.0b013e31817b6dec","article-title":"Gluten-dependent small bowel mucosal transglutaminase 2\u2013specific IgA deposits in overt and mild enteropathy coeliac disease","volume":"47","author":"Koskinen","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R21-9-20240829","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/MPG.0000000000003540","article-title":"ESPGHAN position paper on management and follow-up of children and adolescents with celiac disease","volume":"75","author":"Mearin","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R22-9-20240829","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00431-021-04318-2","article-title":"Follow-up practices for children and adolescents with celiac disease: Results of an international survey","volume":"181","author":"Wessels","year":"2022","journal-title":"Eur J Pediatr"},{"key":"R23-9-20240829","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3945\/an.116.013292","article-title":"Pediatric celiac disease: Follow-up in the spotlight","volume":"8","author":"Valitutti","year":"2017","journal-title":"Adv Nutr"},{"key":"R24-9-20240829","doi-asserted-by":"crossref","first-page":"e2021051332","DOI":"10.1542\/peds.2021-051332","article-title":"IgA Nephropathy as the initial presentation of celiac disease in an adolescent","volume":"148","author":"Slavin","year":"2021","journal-title":"Pediatrics"}],"container-title":["Saudi Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_326_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:13:07Z","timestamp":1787757187000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjg.sjg_326_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/sjg.sjg_326_22","relation":{},"ISSN":["1319-3767"],"issn-type":[{"value":"1319-3767","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]}}}